Federal Agency for Medicines and Health Products

The Federal Agency for Medicines and Health Products (FAMHP) of Belgium is responsible for the approval and registration of new medication in Belgium and for pharmacovigilance. Hugues Malonne is the current CEO of the agency.

The Dutch name is Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG) and in French it is called Agence Fédérale des Médicaments et des Produits de Santé (AFMPS).

The agency succeeded the Directoraat-generaal Geneesmiddelen / Direction Générale des Médicaments of the Federal Public Service Health as the new Competent Authority on 1 January 2007.